Design, synthesis and in vitro activities of a series of benzimidazole/benzoxazole glycoprotein IIb/IIIa inhibitors
- 6 February 1996
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 6 (3) , 339-344
- https://doi.org/10.1016/0960-894x(95)00590-p
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Antithrombotic agents: From RGD to peptide mimeticsBioorganic & Medicinal Chemistry, 1995
- Template-Constrained Cyclic Peptides: Design of High-Affinity Ligands for GPIIb/IIIaJournal of the American Chemical Society, 1994
- Structural Studies of a Family of High Affinity Ligands for GPIIb/IIIaJournal of the American Chemical Society, 1994
- Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.Circulation, 1994
- Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptorJournal of Medicinal Chemistry, 1993
- Antiplatelet Efficacy and Specificity of DMP728, a Novel Platelet GPIIb/llla Receptor AntagonistCardiology, 1993
- GPIIb-IIIa: The responsive integrinCell, 1991
- Platelets and Thrombolytic TherapyNew England Journal of Medicine, 1990
- Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.Circulation, 1985
- A Facile Synthesis of 2-Substituted BenzoxazolesSynthesis, 1982